AI-powered search
Try Polaris, our new AI-powered search!

What is the benefit of ruxolitinib over topical PDE-4 inhibitors?

Featuring Linda Stein Gold, MD | Co-Director |

Director Clinical Research 
Henry Ford Health System 
Detroit, MI

| Published November 01, 2023

More from this series

Related Media

Powered by Polaris TM